Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the "burden" on ...

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...